Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 3
2015 4
2016 4
2017 3
2018 4
2019 5
2020 4
2021 4
2022 6
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models.
Kim H, Xu H, George E, Hallberg D, Kumar S, Jagannathan V, Medvedev S, Kinose Y, Devins K, Verma P, Ly K, Wang Y, Greenberg RA, Schwartz L, Johnson N, Scharpf RB, Mills GB, Zhang R, Velculescu VE, Brown EJ, Simpkins F. Kim H, et al. Among authors: kinose y. Nat Commun. 2020 Jul 24;11(1):3726. doi: 10.1038/s41467-020-17127-2. Nat Commun. 2020. PMID: 32709856 Free PMC article.
CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models.
Xu H, George E, Kinose Y, Kim H, Shah JB, Peake JD, Ferman B, Medvedev S, Murtha T, Barger CJ, Devins KM, D'Andrea K, Wubbenhorst B, Schwartz LE, Hwang WT, Mills GB, Nathanson KL, Karpf AR, Drapkin R, Brown EJ, Simpkins F. Xu H, et al. Among authors: kinose y. Cell Rep Med. 2021 Sep 23;2(9):100394. doi: 10.1016/j.xcrm.2021.100394. eCollection 2021 Sep 21. Cell Rep Med. 2021. PMID: 34622231 Free PMC article.
Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A, Sawada K, Kobayashi M, Yamamoto M, Yagi T, Kinose Y, Kodama M, Hashimoto K, Kimura T. Shimizu A, et al. Among authors: kinose y. Mol Cancer Res. 2021 Sep;19(9):1583-1595. doi: 10.1158/1541-7786.MCR-20-0956. Epub 2021 May 20. Mol Cancer Res. 2021. PMID: 34016744
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.
Papp E, Hallberg D, Konecny GE, Bruhm DC, Adleff V, Noë M, Kagiampakis I, Palsgrove D, Conklin D, Kinose Y, White JR, Press MF, Drapkin R, Easwaran H, Baylin SB, Slamon D, Velculescu VE, Scharpf RB. Papp E, et al. Among authors: kinose y. Cell Rep. 2018 Nov 27;25(9):2617-2633. doi: 10.1016/j.celrep.2018.10.096. Cell Rep. 2018. PMID: 30485824 Free PMC article.
The role of microRNAs in ovarian cancer.
Kinose Y, Sawada K, Nakamura K, Kimura T. Kinose Y, et al. Biomed Res Int. 2014;2014:249393. doi: 10.1155/2014/249393. Epub 2014 Sep 10. Biomed Res Int. 2014. PMID: 25295252 Free PMC article. Review.
Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy.
Kuruma A, Kodama M, Hori Y, Sato K, Fujii M, Isohashi F, Miyoshi A, Mabuchi S, Setoguchi A, Shimura H, Goto T, Toda A, Nakagawa S, Kinose Y, Takiuchi T, Kobayashi E, Hashimoto K, Ueda Y, Sawada K, Morii E, Kimura T. Kuruma A, et al. Among authors: kinose y. Cancers (Basel). 2022 Dec 28;15(1):170. doi: 10.3390/cancers15010170. Cancers (Basel). 2022. PMID: 36612167 Free PMC article.
41 results